Download programme pdf document

The organisation keeps the right to make changes to the programme at any time.

  • 08:00

    CxO breakfast meeting: for CEOs, CFOs, COOs and CBOs active in the life sciences sector

    Besides a nice and healthy breakfast new companies that started their business recently at the Leiden Bio Science Park will introduce themselves to the Life Sciences community.

    Limited places are available and only to MT members from (R&D) life sciences companies who are attending the conference.

  • 08:00

    Investors forum part 1 - breakfast session -

    Hosted by Johnson & Johnson Innovation

    The investors forum is an exciting opportunity for those companies looking for equity capital and/or partnerships with companies and institutes across the life sciences value chain, from biotech, med tech and pharma companies to financiers and universities. The forum offers excellent opportunities for presenting your company or university to all major Dutch life sciences investors and discuss your business strategy, technology direction and capital-raising plan.

  • 08:45

    Exhibition and Innovation square

    Present your company, products, technology or service. Open from 08:45 till 19:30 hours.

    The Innovation square is hosted by V.O.Patents & Trademarks

  • 09:30

    Plenary opening programme

    • Welcome by chair

      Our chair, Ida Haisma, Director Leiden Bio Science Park will guide us through the plenary programme.

    • Opening

      Hosted by Leiden Bio Science Park

      Opening by Carmen van Vilsteren, Chair Top Sector Life Science & Health

    • Keynote lecture about novel manufacturing solutions for the rapid and cost-effective development of vaccines

      by Dr. Menzo Havenga, President & CEO Batavia Biosciences

      There is a constant demand for more affordable vaccines for global health (polio, measles, rubella), as well as new vaccines to protect against emerging virus outbreaks, such as Ebola, Lassa, Marburg, and coronavirus. To keep up with such demand, breakthrough technologies and global collaborations are required that allow flexible, cost-effective and rapid vaccine development. In this presentation, promising novel technologies, flexible manufacturing solutions and views on collaborations within the industry will be presented. These innovations have demonstrated to substantially lower the cost of goods and increase speed of manufacturing. Such innovations are deemed critical to stay ahead of the game and keep millions of people from dying from vaccine preventable diseases.

    • Keynote lecture

      by Arjen Schippers, Senior Director and Program Head at Europe Cell Therapy Facility, Bristol Myers Squibb Leiden

    • Venture Challenge

      Hosted by Health~Holland 

      by Dr. ir. Chrétien Herben, Program Director LifeSciences@Work

  • 10:55


    Time for networking and to visit the exhibition and innovation square.

  • 11:30

    Parallel morning sessions

    The Nagoya protocol: its impact on research and development in life sciences

    Hosted by V.O.Patents & Trademarks

    Presentations by:
    Dr. Martin Brink, Policy Advisor at Centre for Genetic Resources, WUR
    Carolina dos Santos Ribeiro MSc, PhD candidate, Senior Policy Advisor at RIVM - Center for Infectious Desease Control (CIB)

    Advanced biopharmaceutical manufacturing

    Hosted by Pivot Park

    Presentations by:
    Mireille Sanders MSc, Chief Operations Officer at Pharming Group NV
    ▪ To be announced
    Dr. Nettie Buitelaar, Chief Business Officer at BiosanaPharma

    Medical devices to respond to urgent needs

    Hosted by Quality by Design

    Presentations by
    ▪ Koen Beyers, Founder & Board Member at Voxdale
    ▪ David Nauwelaers, Director of Manufacturing miDiagnostics

  • 12:45


    Time for networking and to visit the exhibition and innovation square.

    Q&A: Funding opportunities of Top Sector Life Sciences & Health @ Health~Holland Booth
    Are you in search of suitable ways to fund your innovative R&D solutions in the Life Sciences & Health (LSH) sector and are you part of a public-private partnership? Then come to the Q&A session of the Top Sector LSH and get informed. Three of our experts are happy to give you insight in the Top Sector’s funding opportunities and the terms and conditions.

  • 14:00

    Parallel afternoon programme

    Breakthrough technologies in life sciences

    Hosted by Leiden Bio Science Park 

    Presentations by.
    Jos Lunenberg MSc, MBA, Founder & CEO at ENPICOM BV
    Dr. Kirsten Schimmel, Ziekenhuisapotheker ¦ Sectiehoofd Bereidingen ¦ Associate Professor Drug Manufacturing at LUMC
    Frederico Muffatto, CEO Digi.Bio

    Human Microbiome: Novel therapeutic strategies and market developments

    Hosted by PwC

    Presentations by:
    Dr. Dries Budding, CEO inBiome
    Marco van Es, Founder Bac2nature
    Dr. Jonathan de Jonge, COO ARTPred

    Cell- and gene based therapeutics

    Hosted by Progress-PME

    Presentations by
    Dr.Ir. Hugo Cueto Rojas, USP Lead Scientist uniQure
    Marc Kamp, Executive Director Quality, Neogene Therapeutics
    Melissa van Pel, PhD., Head of Cell Therapy NecstGen

  • 15:15


    Time for networking and to visit the exhibition and innovation square.

  • 16:00

    Plenary closing programme

    • Wrap up conference

    • Announcement winner Investors Forum

      The winner of the Investors Forum will be awarded a partnering ticket, national or international with a total value of EUR 2,500 and will present their pitch.

    • Mibiton Quality Certificate

      Already more than twenty-five years, dozens of young Life Sciences companies has already been able to accelerate their development, by using a Mibiton investment to purchase state-of-the art lab facilities or to produce first series of medical devices or agro-food production facilities. This year, the stem cell company Ncardia, with facilities at the Leiden Bio Science Park, was selected to receive the bi-annual “Mibiton Quality Certificate”. CEO Stefan Braam will briefly elaborate on the recent developments of his company, including the impact of both Mibiton investments.

    • Closing keynote lecture ´The positive side-effects of the COVID-19 pandemic´

      by Hans Schikan, PharmD, Special Envoy Vaccines Dutch Ministry of Health, Welfare and Sport

      The ongoing COVID-19 pandemic is devastating, for individual people, societies at large and economies alike. At the same time, due to this ‘external enemy’ the world has seen unprecedented collaboration, speedy review of innovations and risk sharing between the public and private sector. Which of these ‘positive side-effects’ of the pandemic should we try to foster and keep, also in the post-pandemic era? What are the lessons learnt?

  • 17:15


    Drinks, bites, networking and visit the exhibition and innovation square!

Stay up to date with the latest news!

Newsletter subscribe